Broad Street Angels Hears Pitches from 3 Female CEO Entrepreneurs

Startups are alive and well and run by women at July’s Broad Street Angels investment meeting.

July 11, 2020
Author: Susan Yee
Category/Tags: Just published

Philadelphia, PA – Open for business and selecting high growth companies to pitch its members for investment, the Broad Street Angels held its July investment meeting with a lineup of 3 dynamic female CEO led companies.

Mytonomy – a cloud-based platform that educates, activates and empowers patients to achieve better health outcomes by helping them better self-manage their conditions. Anjali Kataria, CEO

Stimulus –  a relationship intelligence platform that uses data & analytics to help companies make better purchasing decisions. We leverage API’s from internal and external data sources to provide visibility, enhance decision-making and to promote communication of supplier utilization. This allows teams to avoid risks and save costs by identifying business opportunities and disruptions across the supply chain. Tiffanie Stanard, CEO

CytoAgents –  a clinical-stage biotech company focused on the development of innovative pharmaceutical products for the treatment of COVID-19, influenza, viral infectious diseases and conditions that cause acute respiratory distress. Our lead compound, GP1681, targets the underlying cause of life-threatening respiratory distress, cytokine release syndrome, by modulating the body’s natural immune response to sickness or disease. Teresa Whalen, CEO

About Broad Street Angels
Broad Street Angels is an Affinity Club of the Union League of Philadelphia with nearly 100 accredited investors as members. For more information, please contact Susan Yee, Chair – Communications Committee,, 610-997-8100